Colin Hill, CEO and co-founder of GNS Healthcare participated on a panel at the 14th Annual Personalized Medicine Conference, held Wednesday, November 14th. The panel, “Automating Actionable: How Artificial Intelligence is Charting a Course for Personalized Medicine in Oncology and Beyond”, featured industry leaders from across the healthcare ecosystem to discuss how AI is currently impacting the practice of precision medicine. Other panelists included: Gregg Talbert, PhD, Global Head of Digital and Personalized Health Care Partnering at Roche; Tom Miller, Managing Partner at GreyBird Ventures LLC; andDarrell West, PhD, Vice President and Director of Governance Studies and Founding Director of the Center for Technology Innovation at Brookings Institution.

More information on the panel and the entire program can be found here.